Affy Will Use $90M Illumina Settlement Bounty on R&D Projects, Acquisitions

The settlement ends more than three years of litigation between the companies, though patent re-examinations of Affy IP filed by Illumina will proceed and the possibility of future litigation between the array vendors exists.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories